Major strategic initiatives, including demerger, to transform CSL MELBOURNE, Aug. 19, 2025 /PRNewswire/ — Global biotherapeutics leader CSL today announced a reported net profit after tax of US$3.0 billion for the 12 months ended 30 June 2025, up 17% on a constant currency basis….
